ZBH
NYSE:ZBH
Zimmer Biomet Holdings, Inc.
- Stock
101.82
−1.19%
−1.40
news - Aug 13, 2025 - 22:46
Orthopedic Devices Market Poised for 4.78% CAGR Growth Through
The global orthopedic devices market is projected to grow from USD 44.09 billion in 2023 to USD 57.79 billion by 2030 at a compound annual growth rate (CAGR) of 4.78%, driven by rising musculoskeletal disorders, demographic aging, and technological innovation. Key drivers include increasing prevalence of osteoarthritis (528 million cases) and rheumatoid arthritis (18 million cases), as well as advancements in AI-enabled devices, biocompatible materials, and minimally invasive surgical tools. Major companies such as Stryker, Zimmer Biomet, Johnson & Johnson, Medtronic, Maxx Orthopedics, Hyalex Orthopaedics, and OrthoPreserve are at the forefront of innovation, with recent FDA approvals and breakthrough designations for devices like the SetPoint System, Freedom Total Knee System, Freestyle Knee Implant, and Defender meniscus replacement. The market is shaped by competitive dynamics involving in-licensing, partnerships, and strategic M&A, with growing focus on personalized implants, tele-enabled surgery, and value-based healthcare models.
openpr.comnews - Aug 13, 2025 - 16:12
Arthroscopy Device Market to Reach USD 12.85 Billion by 2034 | Arthrex, Stryker, Zimmer Biomet Lead - Fact.MR
The global arthroscopy device market is projected to grow from USD 7.98 billion in 2024 to USD 12.85 billion by 2034, at a CAGR of 4.9%. Driven by rising orthopedic conditions, sports-related injuries, and advancements in minimally invasive surgical technologies, demand is increasing, particularly in North America and East Asia. Key players including Arthrex, Stryker, and Zimmer Biomet dominate the market through innovation, strategic acquisitions, and product development. The hospital segment is the largest end-user, with arthroscopic implants and visualization systems showing strong growth. Challenges such as high costs, regulatory hurdles, and product recalls remain, prompting companies to focus on cost-effective solutions and strategic partnerships.
openpr.comnews - Aug 13, 2025 - 14:05
Periodontal Disease Market Set to Grow from USD 15.8 Billion in 2024 to USD 27.6 Billion by 2034
The global periodontal disease market is projected to grow from USD 15.8 billion in 2024 to USD 27.6 billion by 2034, reflecting a compound annual growth rate (CAGR) of 5.7%. This growth is driven by rising disease prevalence, technological innovations in treatment, and increased integration of dental care into public health systems. Key growth areas include minimally invasive laser therapies, regenerative treatments, and digital dentistry. North America currently holds the largest market share, followed by Europe, while Asia-Pacific is the fastest-growing region due to expanding disposable incomes, government investments, and rising dental tourism. Major players such as Dentsply Sirona, Straumann Group, Danaher Corporation, Colgate-Palmolive, 3M Company, Zimmer Biomet, Medtronic, BioHorizons, Nobel Biocare, Henry Schein, Hu-Friedy, Planmeca Oy, GC Corporation, Ivoclar Vivadent, and Young Innovations are shaping the market through innovation, strategic expansions, and investments in training and emerging markets.
openpr.comnews - Aug 12, 2025 - 19:00
Erectile Dysfunction Devices Market Set to Surge at a CAGR
The global erectile dysfunction devices market is expected to grow at a compound annual growth rate (CAGR) of approximately 8% by 2032, reaching a market size of USD 3 billion. The expansion is driven by rising incidences of erectile dysfunction linked to chronic conditions such as diabetes, cardiovascular disease, hypertension, and obesity, as well as an aging male population. North America led the market in 2024 due to high prevalence rates and increasing awareness. Key players include Comphya SA, Coloplast Group, Boston Scientific Corporation, and others. Innovations such as Comphya's CaverSTIM implantable neuromodulator, which received FDA IDE approval in January 2025, are advancing treatment options. However, high device costs and complexity remain significant barriers to adoption, especially in developing regions.
globenewswire.comnews - Aug 12, 2025 - 18:33
Sleep Apnea Devices Market Poised for Steady Growth, Fueled
The global sleep apnea devices market was valued at USD 3.64 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.37% from 2024 to 2030, reaching USD 6.19 billion by 2030. This growth is driven by increasing incidences of chronic conditions such as cardiovascular diseases and cancers, an aging population, and technological advancements in device design. North America is expected to dominate the market during the forecast period due to high prevalence of vertebral compression fractures and chronic pain. Key companies including Zimmer Biomet, Stryker, Medtronic, Orthofix Medical Inc., NuVasive Inc., B. Braun Melsungen AG, Neo Medical SA, and others are active in the market. Recent developments include Cerapedics receiving FDA approval for PearlMatrixTM P-15 in June 2025, Neo Medical SA achieving full EU MDR certification in December 2024, and Orthofix Medical launching the WaveForm L Lateral Lumbar Interbody System in November 2023.
openpr.comDescription
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremit...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus